Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
100%
Chemotherapy
100%
Epidermal Growth Factor Receptor 2
100%
Trastuzumab
100%
Gamma Urogastrone
100%
Anthracycline
58%
Malignant Neoplasm
25%
Treatment Group
16%
Overall Survival
8%
Cyclophosphamide
8%
Doxorubicin
8%
Cardiotoxicity
8%
Carboplatin
8%
Docetaxel
8%
Disease Free Survival
8%
Assessment Factor
8%
Nursing and Health Professions
Breast Cancer
100%
Gamma Urogastrone
100%
Epidermal Growth Factor Receptor 2
100%
Trastuzumab
100%
Anthracycline
58%
Treatment Group
16%
Adjuvant Therapy
16%
Adjuvant Chemotherapy
16%
Cancer Therapy
16%
Health Care Quality
8%
Malignant Neoplasm
8%
Carboplatin
8%
Cardiac Event
8%
Overall Survival
8%
Cyclophosphamide
8%
Doxil
8%
Disease Free Survival
8%
Docetaxel
8%
Cardiotoxicity
8%